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Abstract
Although adult soft tissue sarcoma is a rare disease, it needs individual treatment by an experienced, interdisciplinary
team. We present an exceptional case of a 36-year-old woman suffering from a giant intermediate grade myxoid liposarco-
ma of the left buttock. She had been seen 4 years earlier but refused to undergo any treatment by then. Now suffering from
a foul, ulcerating and superinfected tumor she agreed to surgical treatment. Despite delay, treatment could be performed
according to the most up to date sarcoma guidelines which are discussed, including a brief review of the literature.
INTRODUCTION
Adult soft tissue sarcomas are rare tumors, with an estimated
incidence averaging 4–5/100 000/year in Europe [1]. Adipocytic
tumors represent the largest subgroup, of which liposarcoma is
the most common [2]. The unusual clinical course over a 4-year
time span of a slowly growing, eventually necrotizing,
untreated gluteal myxoid liposarcoma in a young Swiss woman
is described and the outcome after surgery reported.
CASE REPORT
A woman 36 years of age presented with a painless, slowly
growing mass of the left buttock (Fig. 1). Magnetic resonance
showed an inhomogeneous tumor of 10 × 8.5 × 6 cm3 in size
suspicious for myxoid sarcoma (Fig. 2). Biopsy was recommended.
However, the patient refused and was lost for follow-up. Three an
a half years later, the anemic patient was referred again, now with
a giant 22 × 19 × 24 cm3 measuring, foul, ulcerating and bleeding
tumor (Fig. 3), partly infiltrating the gluteus maximus muscle (Fig
4). Myxoid sarcoma was confirmed by three deep punch biopsies
in local anesthesia followed by swift surgical resection.
The patient was put in prone position under general anes-
thesia and the operating site desinfected with Povidone Iodine
solution. The operation field was additionally covered with an
Iodine impregnated incision drape to further minimize bacter-
ial contamination. The skin was incised circumferentially, min-
imally 1 cm away from the palpable tumor mass, until reaching
the fascia of the gluteus maximus muscle. The tumor was then
resected circumferentially including parts of the gluteus
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maximus muscle and its fascia leaving the sciatic nerve and
the external anal sphincter untouched. Wound closure was
achieved after epifascial mobilization, followed by uneventful
wound healing and an acceptable aesthetic result (Fig. 5).
Pathohistological workup confirmed wide resection (R0) of an
intermediate grade myxoid liposarcoma Grad 2 according to
the French Federation of Comprehensive Cancer Centers
(FFCCC), weighing 5.6 kg and measuring 26 × 24 × 15 cm3. After
interdisciplinary discussion at the in-house sarcoma board, no
radiation therapy was recommended.
DISCUSSION
At first encounter with an experienced tumor surgeon, the
patient denied to take biopsies due to personal conviction and
was lost for follow-up. Four years later, the tumor had grown
enormously, was partially necrotic and infected in an anemic
patient due to constant bleeding. Nevertheless, the patient
could be treated according to the guidelines from the European
Sarcoma Network Working Group for soft tissue sarcomas [3].
To recapitulate, these emphasize that surgery is the stand-
ard treatment and must be carried out by a surgeon specifically
trained in sarcoma treatment.
Standard surgical procedure is wide excision with negative
margins (R0), implying the removal of the tumor with a rim of
normal tissue around it.
The cut-off for minimal margin on fixed tissue is depending
on several factors (histological subtype, preoperative therapies
and presence of resistant anatomical barriers such as muscular
fasciae, periosteum and epineurium). In the case presented,
tumor invasion into the right gluteal muscle indicated exten-
sion of the resection margin into that muscle.
Radiotherapy is recommended after wide excision as standard
treatment of high-grade, deep and lesions larger than 5 cm. Is the
tumor resected and the compartment contained, radiation therapy
is not indicated. Despite infiltration of the tumor into the gluteus
maximus muscle R0 resection was achieved. After interdisciplinary
discussion radiotherapy was not recommended.
Adjuvant radiotherapy is the standard treatment of high-
grade (G2–3) sarcomas [4] and mostly recommended in lesions
>5 cm, especially when locallized deeply.
Of note, any adjuvant treatment was vehemently refused by
the patient.
Figure 2: Magnetic resonance imaging described a left gluteal tumor, partly situated within the left gluteus maximus muscle, without infiltrating the skin.
Figure 1: Clinical situation in September 2014. The patient noticed a slowly
growing, painless mass on her left buttock.
Figure 3: Clinical situation in March 2018 (3 and a half years after primary find-
ing). A gigantic tumor arose of the left gluteal region, partially necrotic, foul and
with bleeding ulceration.







































































Formulating any prognosis is challenging, especially since
the patient did refuse to undergo any pre- or post-operative
staging procedures. The effect of delayed treatment on out-
come is discussed controversially [5]. Nonetheless, extended
size and depth can influence outcome negatively [6]. However,
the intermediate graded tumor of the extremities [6] remained
untouched during the entire procedure and was entirely (R0)
resected. The patient was treated congruent to the most up-to-
date sarcoma guidelines. Therefore we have reason to believe
that the patient has a fair chance of being cured.
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Figure 4: Magnetic resonance imaging showed a very large tumor of the left gluteal region, further infiltrating the left gluteus muscle and now with infiltration of the
skin.
Figure 5: Intraoperative situation directly after wound closure.
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